Weaver Consulting Group Adamis Pharmaceuticals Corp Transaction History

Weaver Consulting Group

  • $264 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
$0.4 - $1.01 $882 - $2,227
-2,205 Closed
0 $0
Q1 2020

Apr 28, 2020
BUY
$0.33 - $0.89 $727 - $1,962
2,205 New
2,205 $1,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email